Metachronous multiple primary malignancies: a case report of colon and thyroid cancer
DOI:
https://doi.org/10.18203/2320-6012.ijrms20241920Keywords:
Metachronous tumor, Thyroid cancer, Colon cancer, Multiple primary malignanciesAbstract
Cancer remains a challenging disease for our profession despite the medical and technological advances achieved in recent years. This challenge increases when we encounter multiple primary tumors that significantly modify the prognosis of our patients.
Metrics
References
Villalobos C, Ferrer-Rosende P, Cavallera C, Cavada G, Manríquez M, Quirland C, et al. Distribución geográfica de la incidencia de cáncer de beneficiarios de un convenio de atención oncológica en Chile. Revista médica de Chile. 2023;151(3):340-8.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.
Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10(4):264-72.
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer. 2020.
Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer. 1932;16:1358-414.
Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol. 2003;26:79-83.
Li W, Zhan Y, Li G. Double cancers: a clinical analysis of 156 cases. Zhonghua Zhong Liu Za Zhi. 1996;18:296-8.
Lv M, Zhang X, Shen Y, Wang F, Yang J, Wang B, et al. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors. Medicine. 2017;96:17.
Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, et al. Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017;2(2):201.
Alonso H, Las MM, Mas G. Multiple independent primary tumors and second primary neoplasms. Relationship with smoking. Minutes Urol Esp. 2010;34(6):516-21.
Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH. The effect of age and gender on bladder cancer: A critical review of the literature. BJU Int. 2010;105:300-8.
Zhai C, Cai Y, Lou F, Liu Z, Xie J, Zhou X, et al. Multiple Primary Malignant Tumors - A Clinical Analysis of 15,321 Patients with Malignancies at a Single Center in China. J Cancer. 2018;9(16):2795-801.
American Joint Committee on Cancer. AJCC Cancer Staging Manual. 8th edition. Springer International Publishing. 2017.
Heron DE, Komarnicky LT, Hyslop T. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer. 2000;88:2739-50.
Moertel CG, Dockerty MB, Baggenstoss AH. Multiple primary malignant neoplasms. II. Tumors of different tissues or organs. Cancer. 1961;14:231-7.
Chitwood H, Carey T. Managing the Patient With Multiple Primary Tumors. J Adv Pract Oncol. 2023;14(3):218-21.